AzTrials
AzTrials

DementiaNCT02846415

Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study

A study testing Play Intervention for Dementia in people with Dementia and Alzheimer Disease, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study intends to use Play Intervention for Dementia (PID) to promote cognitive functions of people with early to moderate dementia. This is a cluster randomized controlled trial aims to recruit 38 participants from two study sites. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Dementia, Alzheimer Disease
What is being tested?
Play Intervention for Dementia
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteHong Kong
Study dates
1 Aug 2016to 31 Dec 2017
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Community dwelling, at the age of 65 or above
  • With a medical confirmed diagnosis of any type of dementia (such as Alzheimer's disease, vascular dementia, etc.).
  • At the stage of early to moderate dementia, at the stage of 4-6 screened by Global Deterioration Scale

Who cannot join

  • Unable to sit independently and participate in table activities
  • Physically unstable
  • Dislikes group activity

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • School of Nursing, The Hong Kong Polytechnic University

    Hong Kong

Other trials in Hong Kong

About this study

Official title: Play Intervention for Dementia for Promoting Cognitive Function

This study intends to use Play Intervention for Dementia (PID) to promote cognitive functions of people with early to moderate dementia.

This is a cluster randomized controlled trial aims to recruit 38 participants from two study sites. Participants will be randomly allocated into intervention or wait-list controlled groups. Both groups will receive the same content of PID programme at different time. The PID consists of 12 weekly sessions. Each session lasts for 45-75 minutes. The PID will be facilitated by a play specialist, trained elderly volunteers, and centre staffs. Cognitive functions will be evaluated with Montreal Cognitive Assessment, Fuld Object Memory Evaluation and Modified Verbal Fluency Test, conducted by a trained research assistant blinded to group allocation. Centre staffs (not involved in the PID) will be interviewed. Every alternate session will be video-taped for understanding the experience of the participants in the PID programme.

Read the detailed description

Methodology To investigate the feasibility of using Play Intervention for Dementia for enhancing the cognitive functions of people with dementia.

Research objectives

  1. To examine the feasibility of using Play Intervention for Dementia for enhancing cognitive functions.
  2. To explore the effects of Play Intervention of Dementia on cognitive functions.
  3. To examine the experience of participating in the play intervention by people with dementia.

Research design This study is a feasibility study, designed as a cluster randomized controlled trial. Two study sites (day care centres) have agreed to join this project and will be randomly allocated to either PID group, or wait-list control group.

A mixed methods design will be employed to address the three research objectives. To evaluate the feasibility of Play Intervention, information about the ease of recruitment, attendance, occurrence of adverse events during play intervention will be collected. Staff perceptions upon play intervention will be explored through semi-structured interview. To explore the preliminary effects of Play Intervention, participants' cognitive functions will be measured at baseline (T0), after 2 months (T1), and post intervention (T2). To examine the experience of Play Intervention by people with dementia, every alternate session will be videotaped for analysis.

Participants Participating centres will recruit and screen the eligibility of participants. After obtaining initial consent from the potential participants and their next of kin, his/her eligibility will be verified by the research assistant.

Participants are community dwelling, at the age of 65 or above with a medical confirmed diagnosis of any type of dementia (such as Alzheimer's disease, vascular dementia, etc.). He/she is at the stage of early to moderate dementia, at the stage of 4-6 screened by Global Deterioration Scale, and able to sit independently and participate in table activities; and physically stable.

There was no empirical research conducted on play intervention for dementia. As play intervention is regarded as a general cognitive stimulation activity in this study, sample size will be estimated with reference to related literature. Based on the systematic review of cognitive stimulation on cognitive functions, moderate effect size is found (SMD = 0.41, 95% CI = 0.25, 0.57), with the significance level of 0.05, power 0.8. Assuming of 20% attrition rate, 188 participants / group will be needed. This study is a feasibility study, and therefore only 10% of main study will be recruited, i.e. 19 participants/group, 38 participants in total.

Intervention The Play Intervention for Dementia was developed by Prof A. Ka Tat Tsang of the University of Toronto and his research team in 2013. It was based on the Strategies and Skills Learning and Development (SSLD) model, for promoting the quality of life of individuals with dementia. According to the SSLD model, human actions are driven by unmet needs. Maslow (1943) stated that people are motivated to achieve the needs, including physiological needs, safety needs, belonging needs, esteem needs, and self-actualization needs. People with dementia also have these needs, but they have difficulties to satisfy the needs because of the diminished cognitive abilities. Despite of the neuropathological changes caused by dementia, in play intervention, needs of belonging can be satisfied through social interaction in the group activities; needs of esteem can be contented through playing with toys independently in their own way and being respect throughout the process; and needs of self-actualization are fulfilled by realizing one's ability and creativity.

The PID programme has been piloted in Yee Hong Geriatric Centre, Toronto, Canada and Yan Oi Tong Day Care Centre of Hong Kong. Other than the intended outcomes (i.e. mood and quality of life), general improvement in cognitive functions (including attention, memory, quantitative ability, responsiveness, verbal expression) was noted by the family relatives and the researchers.

This study will replicate the intervention conducted in the previous trials. Each group will consist of 12 - 20 elderly, who will be further divided into three to four subgroups. They will participate in a 12 weekly session for 45 - 75 minutes. In each session, the participants will have warm up activities and play with toys with the other members in the subgroup. The toys have different characteristics that would stimulate gross/fine motor skills, proprioception, neuro-corporeal integration, sensory-motor coordination, cognitive capacity, and emotional expression. Examples of these toys are Jenga, Domino, Board Games, beach ball and plush toy. The session will conclude with playing a percussive music instrument. Play assistant (trained elderly volunteer) will facilitate the play intervention by setting up the play area, encouraging participation, offering assistance with minimal instructions, providing attention, and ensuring safety. They will transfer toys between subgroups every 8 - 10 minutes. It is because Mayer and Griffin (1990) found that people with dementia would show considerable interest on toys and engage in stimulus-seeking and exploring behavior within 10 minutes during unstructured active play. Play assistants will be trained by a Play Specialist. Participants will remain seated at the same table. The intervention fidelity will be monitored through the programme by a Play Specialist.

The Play Specialist possesses a professional qualification in one of the human service professions by licensing or regulatory authorities (e.g. registered nurse, registered social workers), and has successfully completed at least 30 hours of SSLD and Play Intervention training in a recognized or accredited programme.

Wait-list control condition The control group will receive standard care only until the last data collection was conducted in the experimental group. Standard care consists of medical and personal care, provision of basic needs, and activities carried out as usual.

Measurements Demographic data including age and gender, socioeconomic and educational background, medical history, living arrangement and marital status will be collected.

The global cognitive functions of the participants will be assessed with the Hong Kong version of Montreal Cognitive Assessment which has excellent inter-rater reliability and good discriminatory ability. It consists of 11 questions and takes around 15 minutes to complete.

Fuld Object Memory Evaluation (FOME) will be used for evaluating memory functions of encoding, storage, and recall across five recall trials and a delayed recall trial. This instrument has been validated in the Hong Kong Chinese population with good test-retest reliability, convergent validity, and discriminative power, and independent to educational background. Verbal fluency will be assessed by the Modified Fuld Verbal Fluency (MVFT). This instrument is modified from the original Fuld Verbal Fluency Test with cultural adaptation, which is a part of the FOME. The FOME and MVFT will take only 15 minutes to complete.

Semi-structured interview

At post-intervention, semi-structured interviews with staff will be conducted to explore their perception of play intervention and its effects on participants with the intervention group. Responsible programme workers or social workers from two study sites will be invited. The questions will be but not limited to:

  1. Do you think play intervention can have a positive or negative effect on the participants?
  2. Have you seen a change in participants' symptoms or well-being since they start receiving play intervention?

Video-taped The engagement of participants in the play intervention will be analyzed by watching the videotapes and filling in a log-sheet by the play assistants. In the log sheet, (a) total time spent, (b) names of all the activities participants engaged in and time spent on each toy, (c) level of engagement, (d) assistance participants needed, (e) participants' verbal and nonverbal reactions, and (f) barriers to engagement in activities will be recorded.

Data collection procedure A trained research assistant will be responsible for data collection and the semi-structured interview. He/she will be blinded to group allocation.

Ethical considerations Ethical approval will be sought from the University and participating organization. The participation will be entirely voluntary. Verbal explanation and information sheet will be given to the participants and their next of kin. Written consent will be sought from next of kin. Staff to be interviewed will also be explained about the study, and their informed consent will be sought too. Participants and their next-of-kin, and staff are free to withdraw anytime of the study without any penalty. Before each session, participates will be invited to join the play intervention. If he/she declined twice, his/her decision will be respected, but the play assistant and centre staff will invite again in the later session.

The play intervention is regarded safe and no side effect has been reported. However, if there is emotional upset or any other adverse reaction, the participant will be brought away from the venue and referred to the centre social worker for follow-up. The participant may choose to continue or withdraw from the next intervention session. The questions being asked by the research assistant during data collection are neutral and should not arouse any negative feeling. However, if emotional upset is observed, the research assistant will try to comfort the participant and refer to the social worker immediately. All the data collected will be kept confidential, while only the research team can retrieve. Individual identity would not be revealed in any published materials.

Data analysis strategies

The statistical software SPSS 23.0 will be used for data entry and analysis. As this study will adopt cluster randomization, characteristics of participants from the same centre may be correlated. The Generalized Estimating Equation (GEE) model will be used to conduct the repeated measurement analysis and correct the within cluster correlation. In all analysis, 5% significance level will be used. 95% Confident interval will be calculated.

The interviews will be audio-taped, transcribed and then subjected to thematic analysis by two researchers to elicit concisely described patterns and themes.

Being tested
Play Intervention for Dementia
Keywords
Dementia, Play and Playthings, Cognition, Memory
Medical subject headings
Dementia, Alzheimer Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Play Intervention for DementiaBehavioural

    1. 8 weekly session, 45-75 minutes each
    2. Play with toys
    3. Sessions will be facilitated by a play specialist, trained play assistants, and centre staff.
Study groups in NCT02846415
Study groupRoleWhat they receive
PID groupExperimentalExperimental group receiving the Play Intervention for Dementia
Receives: Behavioral: Play Intervention for Dementia
Wait-list control groupNo interventionParticipants will receive usual care offered by the day care centre, including health and social services, and meals, etc.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adjusted Post-test Score of Montreal Cognitive Assessment Scale After 2 Months of Intervention

    The Hong Kong version of the 11-item Montreal Cognitive Assessment scale was used to measure the global cognitive functions of the participants. The scores range from 0 to 30, and lower scores refer to lower levels of cognitive function. The scores reported are the adjusted post-test mean scores using its baseline measures as a covariate in ANCOVA.

    Measured: At Baseline, after 2 months (T1)

Secondary outcomes (2)
  1. Adjusted Post-test Score of Fuld Object Memory Evaluation - Total Storage Score

    The 10-item Fuld Object Memory Evaluation was used to measure memory of participants. The total storage (score range: 0 to 50) was reported. Higher scores refer to better memory. The scores reported are the adjusted post-test mean scores using its baseline measures as a covariate in ANCOVA.

    Measured: At Baseline, after 2 months (T1)

  2. Adjusted Post-test Score of the Modified Verbal Fluency Test

    The Modified Fuld Verbal Fluency test was used to assess verbal fluency by asking participants to name animals, fruits and vegetables in 1 minute or 30 seconds. The scores were the sum of the items being recalled, and higher total scores refer to better verbal fluency. The scores reported are the adjusted post-test mean scores using its baseline measures as a covariate in ANCOVA.

    Measured: At Baseline, after 2 months (T1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2016 (estimated)
  2. Study start1 Aug 2016
  3. Primary completion30 Apr 2017
  4. Study completion31 Dec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02846415
Sponsor's protocol ID
4-ZZFU
Status last verified
Oct 2023
First submitted
29 Jun 2016
Last updated
23 Oct 2023
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Woods B, Aguirre E, Spector AE, Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD005562. doi: 10.1002/14651858.CD005562.pub2.

    PubMed 22336813
  • Connelly LM. Pilot studies. Medsurg Nurs. 2008 Dec;17(6):411-2. No abstract available.

    PubMed 19248407
  • Chung JC. Clinical validity of Fuld Object Memory Evaluation to screen for dementia in a Chinese society. Int J Geriatr Psychiatry. 2009 Feb;24(2):156-62. doi: 10.1002/gps.2085.

    PubMed 18612999
  • Chiu HF, Chan CK, Lam LC, Ng KO, Li SW, Wong M, Chan WF. The modified Fuld Verbal Fluency Test: a validation study in Hong Kong. J Gerontol B Psychol Sci Soc Sci. 1997 Sep;52(5):P247-50. doi: 10.1093/geronb/52b.5.p247.

    PubMed 9310094
  • Fuld PA. Fuld Object Memory Evaluation Manual. Stoelting: Wood Dale, IL.1981.

  • Yeung PY, Wong LL, Chan CC, Leung JL, Yung CY. A validation study of the Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) in Chinese older adults in Hong Kong. Hong Kong Med J. 2014 Dec;20(6):504-10. doi: 10.12809/hkmj144219. Epub 2014 Aug 15.

    PubMed 25125421

Questions about this trial

What is this clinical trial studying?

A study testing Play Intervention for Dementia in people with Dementia and Alzheimer Disease, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 3 Dec 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adjusted Post-test Score of Montreal Cognitive Assessment Scale After 2 Months of Intervention (time frame: At Baseline, after 2 months (T1)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02846415, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT02846415 | AzTrials